Industry Reports
WuXi AppTec Acquires Biology Focused R&D Service Leader HD Biosciences
WuXi AppTec, a leading global pharmaceutical, biotechnology and medical device open-access capability and technology platform announced that it has acquired HD Biosciences (HDB), a...
Press Releases
Gilead Sciences, Inc. Announces EMA Validation of Marketing Authorization Application for Investigational Chronic
Gilead Sciences, Inc announced that the company’s Marketing Authorization Application for the investigational, once-daily, single tablet regimen of sofosbuvir 400 mg. ...
Press Releases
Takeda Recognized as one of the Global 100 Most Sustainable Corporations for second consecutive year
Takeda Pharmaceutical Company Limited ,is proud to be named by Corporate Knights to the 2017 Global 100 Most Sustainable Corporations in the World Index....
Drug Research
PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious Diseases
PharmAthene, Inc. and Altimmune, Inc., a privately-held immunotherapeutics company targeting infectious diseases, announced the signing of a definitive agreement for the merger of PharmAthene...
Drug Research
Evotec enters into an integrated drug discovery collaboration with Asahi Kasei Pharma
Evotec AG announced it has entered into an integrated drug discovery collaboration on an ion channel target with Asahi Kasei Pharma Corporation, a wholly...
Clinical Trials
New UK primary care clinical trials company Interface Clinical Research to offer a more effective model
New clinical trials company, Interface Clinical Research, outlined a new model for running primary care clinical trials at their launch yesterday at the Royal...
Press Releases
MRC Technology, Cancer Research UK and Cancer Research Technology collaborate to focus on cancer immunotherapies
Cancer Research UK, Cancer Research Technology and MRC Technology are joining forces to identify and validate novel drug discovery targets that could lead to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read